Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease
about
Hypometabolism as a therapeutic target in Alzheimer's diseaseAPOE genotype and stress response - a mini reviewTriad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal SexBiochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's diseaseAPOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.Vascular health risks and fMRI activation during a memory task in older adultsApolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.Ketone bodies as a therapeutic for Alzheimer's disease.Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.A FDG-PET Study of Metabolic Networks in Apolipoprotein E ε4 Allele Carriers.Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia.Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism.FDG-PET Contributions to the Pathophysiology of Memory Impairment.Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset.
P2860
Q21262020-3308598D-C532-4825-8E79-41AF71B36DF8Q26741633-A3BD076F-CF60-4BCC-8DE0-E6F4038BD0DCQ28077056-5D2697B0-6425-4BA9-B448-F870F3F90058Q28542628-60974433-6030-40E1-9291-DCCE83012120Q33423191-3ADC6B7A-2FF2-4261-BA4E-1B0B02DBCD0BQ34245836-7BB7E114-A45D-4A52-94C7-C4BE3BA77ACBQ34621541-EAD5E1A1-6C94-40EB-AD5B-868C01ED37A3Q34795761-E050AB30-A36A-49FA-B698-1497EB0648CDQ34988405-CDE1C2A4-CA86-4911-AE8C-62652A054E09Q35483725-793C5E8F-5AFF-404A-B6CB-5281EB5E7596Q35688137-4701180B-99B2-4B8E-ACD2-ECF9B8CB61BAQ35976397-F393B56B-07C2-43E7-BC16-D997DBAEF32AQ36998837-C9158A0B-E9C2-4F76-AAE7-0767DAD1979FQ37098909-51879EBF-2059-4E73-8042-55DAF14419BAQ37544199-598312A3-6349-4DF9-BADE-2BC4A84C5149Q38576278-D0BAF2FF-0AB7-4C5D-B4CB-AC20E0D962B3Q41031850-799FAEFE-2C71-4D42-9B04-AB683332874CQ46019370-37E59FB2-B522-40D9-8612-7CB3C46C2473Q51921138-2A76B05F-B794-419B-9E71-A0C6CDB97FA1
P2860
Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Brain metabolic decreases rela ...... allele in Alzheimer's disease
@ast
Brain metabolic decreases rela ...... allele in Alzheimer's disease
@en
type
label
Brain metabolic decreases rela ...... allele in Alzheimer's disease
@ast
Brain metabolic decreases rela ...... allele in Alzheimer's disease
@en
prefLabel
Brain metabolic decreases rela ...... allele in Alzheimer's disease
@ast
Brain metabolic decreases rela ...... allele in Alzheimer's disease
@en
P2093
P2860
P50
P356
P1476
Brain metabolic decreases rela ...... allele in Alzheimer's disease
@en
P2093
P2860
P304
P356
10.1136/JNNP.2003.014993
P407
P577
2004-03-01T00:00:00Z